Literature DB >> 22315002

A proposed comprehensive classification of tuberculosis disease severity in children.

Catherine A Wiseman1, Robert P Gie, Jeffrey R Starke, H Simon Schaaf, Peter R Donald, Mark F Cotton, Anneke C Hesseling.   

Abstract

BACKGROUND: Tuberculosis (TB) in children has conventionally been classified as pulmonary TB (PTB) and extrapulmonary TB (EPTB) disease, including disseminated TB (TB meningitis and miliary disease). There is no existing approach that comprehensively characterizes the spectrum and severity of pediatric TB. This limits accurate classification of patients and comparison across cohorts. AIMS: To develop a classification of pediatric TB that reflects the spectrum and severity of clinical disease better than currently available approaches.
METHODS: We propose a framework for the standard classification of TB disease severity in children. From a literature search, the following sources of information were used: clinical data, bacteriologic, histopathologic, and imaging data (including information from chest radiography, computerized tomography, and bronchoscopy). Each individual disease entity was systematically considered. Based on the extent and the presence of complications, each entity was then classified as "severe" or "nonsevere." As an initial application, we compared the proposed classification with the convention (PTB, EPTB) in a cohort of HIV-infected and -uninfected infants with culture-confirmed TB. Agreement between the 2 systems was poor.
CONCLUSIONS: The proposed comprehensive disease classification system may more accurately reflect the clinical TB disease spectrum in children, is relevant to clinical management, and may be valuable to inform research on diagnostic tools and TB treatment strategies in children. Prospective studies are required to evaluate this approach in representative pediatric populations, correlating TB disease severity with diagnostic yield, treatment response, and application in existing and novel treatment strategies.

Entities:  

Mesh:

Year:  2012        PMID: 22315002     DOI: 10.1097/INF.0b013e318243e27b

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  32 in total

1.  Xpert MTB/RIF on Stool Is Useful for the Rapid Diagnosis of Tuberculosis in Young Children With Severe Pulmonary Disease.

Authors:  Elisabetta Walters; Marieke Magrieta van der Zalm; Megan Palmer; Corné Bosch; Anne-Marie Demers; Heather Draper; Pierre Goussard; Hendrik Simon Schaaf; Sven Olaf Friedrich; Andrew Whitelaw; Robin Warren; Robert P Gie; Anneke C Hesseling
Journal:  Pediatr Infect Dis J       Date:  2017-09       Impact factor: 2.129

2.  Time to symptom resolution in young children treated for pulmonary tuberculosis.

Authors:  Nkosilesisa Mpofu; Sizulu Moyo; Humphrey Mulenga; Kany Kany A Luabeya; Michele Tameris; Hennie Geldenhuys; Gregory Hussey; Thomas Scriba; Willem Hanekom; Hassan Mahomed; Mark Hatherill
Journal:  Pediatr Infect Dis J       Date:  2014-12       Impact factor: 2.129

Review 3.  Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis.

Authors:  Anne K Detjen; Andrew R DiNardo; Jacinta Leyden; Karen R Steingart; Dick Menzies; Ian Schiller; Nandini Dendukuri; Anna M Mandalakas
Journal:  Lancet Respir Med       Date:  2015-03-24       Impact factor: 30.700

4.  Sonographic Findings of Abdominal Tuberculosis in Children With Pulmonary Tuberculosis.

Authors:  Sabine Bélard; Tom Heller; Viyanti Orie; Charlotte C Heuvelings; Lindy Bateman; Lesley Workman; Martin P Grobusch; Heather J Zar
Journal:  Pediatr Infect Dis J       Date:  2017-12       Impact factor: 2.129

5.  Diagnosis and Management of Multidrug-Resistant Tuberculosis in Children: A Practical Approach.

Authors:  H Simon Schaaf
Journal:  Indian J Pediatr       Date:  2019-01-17       Impact factor: 1.967

6.  A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaques.

Authors:  Kara Jensen; Uma Devi K Ranganathan; Koen K A Van Rompay; Don R Canfield; Imran Khan; Resmi Ravindran; Paul A Luciw; William R Jacobs; Glenn Fennelly; Michelle H Larsen; Kristina Abel
Journal:  Clin Vaccine Immunol       Date:  2012-06-13

7.  Use of procalcitonin in the diagnosis of tuberculosis in infants and preschool children.

Authors:  Eneritz Velasco-Arnaiz; Esther Pérez; Desirée Henares; Anna Fernández-López; Anna Valls; Pedro Brotons; Clàudia Fortuny; Antoni Noguera-Julian
Journal:  Eur J Pediatr       Date:  2018-01-27       Impact factor: 3.183

8.  Characterizing Pediatric Tuberculosis with and without Human Immunodeficiency Virus Coinfection in Harare, Zimbabwe.

Authors:  Michelle Earley; Joconiah Chirenda; Alexandra Highet; Hilda A Mujuru; Zhenhua Yang
Journal:  Am J Trop Med Hyg       Date:  2018-07-12       Impact factor: 2.345

9.  Conducting efficacy trials in children with MDR-TB: what is the rationale and how should they be done?

Authors:  J A Seddon; E D Weld; H S Schaaf; A J Garcia-Prats; S Kim; A C Hesseling
Journal:  Int J Tuberc Lung Dis       Date:  2018-05-01       Impact factor: 2.373

Review 10.  World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update.

Authors:  Fuad Mirzayev; Kerri Viney; Nguyen Nhat Linh; Licé Gonzalez-Angulo; Medea Gegia; Ernesto Jaramillo; Matteo Zignol; Tereza Kasaeva
Journal:  Eur Respir J       Date:  2021-06-04       Impact factor: 33.795

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.